Connacht Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,798
| Closed | -$246K | – | 101 |
|
|
2023
Q2 | $246K | Buy |
6,798
+804
| +13% | +$29K | 0.34% | 55 |
|
|
2023
Q1 | $223K | Sell |
5,994
-1,141
| -16% | -$42.4K | 0.1% | 70 |
|
|
2022
Q4 | $323K | Buy |
7,135
+3,960
| +125% | +$179K | 0.15% | 54 |
|
|
2022
Q3 | $222K | Sell |
3,175
-212
| -6% | -$14.8K | 0.16% | 73 |
|
|
2022
Q2 | $227K | Buy |
3,387
+69
| +2% | +$4.62K | 0.1% | 80 |
|
|
2022
Q1 | $273K | Sell |
3,318
-3,138
| -49% | -$258K | 0.14% | 79 |
|
|
2021
Q4 | $947K | Buy |
+6,456
| New | +$947K | 0.92% | 35 |
|